Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;31(4):292-302.
doi: 10.1159/000279768. Epub 2010 Jan 30.

Novel markers of left ventricular hypertrophy in uremia

Affiliations

Novel markers of left ventricular hypertrophy in uremia

Hironori Nakamura et al. Am J Nephrol. 2010.

Abstract

Aims: Left ventricular hypertrophy (LVH) is the most frequent cardiac complication in chronic renal disease. Previous studies implicate elevated serum phosphorus as a risk factor for LVH.

Methods: We treated 5/6 nephrectomized rats with enalapril or enalapril + sevelamer carbonate for 4 months to determine if sevelamer carbonate had an additional beneficial effect on the development of LVH and uremia-induced left ventricle (LV) remodeling.

Results: Uremia increased LV weight and cardiomyocyte size. Enalapril and enalapril + sevelamer blunted the increase in left ventricular weight. Only enalapril + sevelamer diminished the increase in cardiomyocyte size. Uremia increased cyclin D2 and PCNA and decreased p27 protein expression in the heart. Enalapril + sevelamer diminished the decrease in p27 expression caused by uremia. Uremia increased Ki67-positive and phosphohistone H(3)-positive interstitial cells. This was not seen in cardiomyocytes. Multivariable regression analysis showed that increased phosphorus was an independent risk factor for both increased LV weight and cardiomyocyte size.

Conclusions: These data suggest left ventricular remodeling consists of cardiomyocyte hypertrophy and interstitial cell proliferation, but not cardiomyocyte proliferation. p27 and cyclin D2 may play important roles in the development of LVH. In addition, phosphorus can be an independent risk factor for the development of LVH.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Effect of enalapril and the combination of both enalapril and sevelamer carbonate on (a) left ventricular weight (LV) and (b) cardiomyocyte size. aa p < 0.001 vs. NC, b p < 0.01 vs. UE, c p < 0.01 vs. UES, d p < 0.001 vs. NC, and e p < 0.01 vs. NC. ba p < 0.01 vs. NC, b p < 0.05 vs. UES, and c p < 0.05 vs. NC. c Masson trichrome staining of cardiomyocytes in NC, UC, UE and UES rat hearts. Results were expressed as mean ± SEM. p values were obtained by ANOVA followed by Bonferroni post tests. 254 × 190 mm (96 × 96 dpi).
Fig. 2.
Fig. 2.
Western blot analysis showing the effect of enalapril and the combination of both enalapril and sevelamer carbonate on the expression of cyclin D2 in the LV. a Representative Western blot of cyclin D2 and GAPDH (glyceraldehyde 3-phosphate dehydrogenase). b Quantification of several analyses. Cyclin D2 was normalized to GAPDH. Results were expressed as mean ± SEM. p values were obtained by ANOVA followed by Bonferroni post test. a p < 0.01 vs. NC. 254 × 190 mm (96 × 96 dpi).
Fig. 3.
Fig. 3.
Western blot analysis showing the effect of enalapril and the combination of both enalapril and sevelamer carbonate on the expression of p27 in the LV. a Representative Western blot of p27 and GAPDH (glyceraldehyde 3-phosphate dehydrogenase). b Quantification of several analyses. p27 as normalized to GAPDH. Results were expressed as mean ± SEM. p values were obtained by ANOVA followed by Bonferroni post test. a p < 0.01 vs. NC and b p < 0.05 vs. UES. 254 × 190 mm (96 × 96 dpi).
Fig. 4.
Fig. 4.
Western blot analysis showing the effect of enalapril and the combination of both enalapril and sevelamer carbonate on the expression of PCNA in the LV. a Representative Western blot of PCNA and GAPDH (glyceraldehyde 3-phosphate dehydrogenase). b Quantification of several analyses. PCNA was normalized to GAPDH. Results were expressed as mean ± SEM. p values were obtained by ANOVA followed by Bonferroni post tests. a p < 0.01 vs. NC and b p < 0.05 vs. NC. 254 × 190 mm (96 × 96 dpi).
Fig. 5.
Fig. 5.
Effect of enalapril and the combination of both enalapril and sevelamer carbonate on Ki67 expression in the LV. a Quantification of Ki67-positive interstitial cells. a p < 0.01 vs. NC and b p < 0.05 vs. NC. b Immunohistochemical staining for Ki67 (brown in the online version) in the LVs of NC and UC rats. 254 × 190 mm (96 × 96 dpi).
Fig. 6.
Fig. 6.
Effect of enalapril and the combination of both enalapril and sevelamer carbonate on PHH3 expression in the LV. a Quantification of PHH3-positive interstitial cells. a p < 0.05 vs. NC. b Immunohistochemical staining for PHH3 (brown in the online version) in NC and UC LVs. 254 × 190 mm (96 × 96 dpi).

Similar articles

Cited by

References

    1. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186–192. - PubMed
    1. Silberberg JS, Barre PE, Prichard SS, et al. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989;36:286–290. - PubMed
    1. Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis. 1999;34:125–134. - PubMed
    1. London GM. Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial. 2003;16:85–94. - PubMed
    1. Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31:607–617. - PubMed

Publication types

MeSH terms